Key Takeaways
- • Xcellerant Ventures (XVC) announced a strategic partnership with AZ Venture Capital Inc. (AVC) that brings $7 million in new funding to Arizona-based health technology startups.
- • AVC's $5 million investment into XVC's Fund I was the catalyst, and according to general partner Douglas Sylvester, it spurred XVC's investors to add another $2 million to the fund.
- • XVC's portfolio already includes ten healthcare companies, with half headquartered in or having a significant presence in Arizona.
- • The fund focuses on early-stage healthcare companies led by founders with strong intellectual property and a clear vision for improving health outcomes.
Summary
Xcellerant Ventures (XVC), an early-stage venture firm focused on healthcare, has announced a strategic partnership with AZ Venture Capital Inc. (AVC) that makes $7 million in new capital available to Arizona-based health technology startups. The total was made possible by a $5 million investment from AVC into XVC's Fund I, according to the announcement distributed via Business Wire from Scottsdale, Arizona.
Douglas Sylvester, a general partner at XVC, said the AVC commitment "spurred our investors to add $2 million to our Fund," and described the funding as strengthening the state's position as a hub for healthcare innovation. The fund targets early-stage companies led by founders with strong intellectual property and a clear vision for improving health outcomes, with the stated goal of developing solutions that improve patient care, accessibility, and affordability.
AVC describes its role as investing in top-tier venture funds that drive local innovation. James Goulka, President & CEO of AVC, said the partnership reflects the organization's commitment to positioning Arizona as a national leader in health technology. XVC's existing portfolio includes ten healthcare companies, half of which have a headquarters or significant presence in Arizona.
The release frames the investment as supporting economic growth and job creation in the state. Because the announcement is a company-issued press release, its claims about Arizona's trajectory as a national health tech hub are promotional rather than independently verified, and the release does not disclose fund size targets, check sizes, or deal-level terms beyond the aggregate figures cited.
Douglas Sylvester, a general partner at XVC, said the AVC commitment "spurred our investors to add $2 million to our Fund," and described the funding as strengthening the state's position as a hub for healthcare innovation. The fund targets early-stage companies led by founders with strong intellectual property and a clear vision for improving health outcomes, with the stated goal of developing solutions that improve patient care, accessibility, and affordability.
AVC describes its role as investing in top-tier venture funds that drive local innovation. James Goulka, President & CEO of AVC, said the partnership reflects the organization's commitment to positioning Arizona as a national leader in health technology. XVC's existing portfolio includes ten healthcare companies, half of which have a headquarters or significant presence in Arizona.
The release frames the investment as supporting economic growth and job creation in the state. Because the announcement is a company-issued press release, its claims about Arizona's trajectory as a national health tech hub are promotional rather than independently verified, and the release does not disclose fund size targets, check sizes, or deal-level terms beyond the aggregate figures cited.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.